News Theranos unveils new technologies, but concerns linger Desktop testing device and cloud-based diagnostic platform announced.
News Programmable lab-on-chip advancing in trials A digital device the size of a credit card could provide a diagnosis in just minutes for a huge range of conditions.
News GSK pursues $10.6bn takeover of cancer biotech Nuvalent GSK is preparing for its biggest acquisition in more than 10 years, agreeing to buy cancer drug developer Nuvalent for $10.6 billion.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
